Vascular Access Management After Kidney Transplantation Position Paper on Behalf of the Vascular Access Society and the European Kidney Transplant Association

. 2025 ; 38 () : 14712. [epub] 20251113

Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu konsensuální prohlášení, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid41323958

There is no consensus on whether to ligate or preserve uncomplicated vascular access (VA) after kidney transplantation (KT), as International Guidelines do not address this issue. Enhanced survival rates of kidney grafts may elevate the risk of cardiac morbidity and mortality due to prolonged exposure to the hemodynamic effects of arterio-venous fistulas (AVF). Although VA ligation reduces left ventricle (LV) mass, its impact on cardiovascular (CV) morbidity or mortality is unclear. High-flow VAs can complicate KT patients, and immunosuppressive medication may increase these complications. Despite preserving VA for future hemodialysis (HD) use, central catheters are used in nearly two-thirds of patients. Detecting transplant patients who can undergo AVF ligation and reconstruction when returning to HD allows for flexible decision-making with a multidisciplinary approach, personally tailored to patients at their discretion. Therefore, an algorithm involving Doppler ultrasound and cardiac evaluation is advisable.

Erratum v

PubMed

Zobrazit více v PubMed

Poggio ED, Augustine JJ, Arrigain S, Brennan DC, Schold JD. Long-Term Kidney Transplant Graft Survival-Making Progress When Most Needed. Am J Transpl (2021) 21(8):2824–32. 10.1111/ajt.16463 PubMed DOI

Chan MR, Oza-Gajera B, Chapla K, Djamali AX, Muth BL, Turk J, et al. Initial Vascular Access Type in Patients with a Failed Renal Transplant. Clin J Am Socnephrol (2014) 9(9):1225–31. 10.2215/CJN.12461213 PubMed DOI PMC

Arce CM, Lenihan CR, Montez-Rath ME, Winkelmayer WC. Comparison of Longer-Term Outcomes after Kidney Transplantation between Hispanic and Non-Hispanic Whites in the United States. Am J Transpl (2015) 15:499–507. 10.1111/ajt.13043 PubMed DOI

Jardine AG, Gaston RS, Fellstrom BC, Holdaas H. Prevention of Cardiovascular Disease in Adult Recipients of Kidney Transplants. Lancet (2011) 378:1419–27. 10.1016/S0140-6736(11)61334-2 PubMed DOI

Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, et al. Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients. Circulation (2019) 139(25):2809–18. 10.1161/CIRCULATIONAHA.118.038505 PubMed DOI

Salehi T, Montarello NJ, Juneja N, Stokes MB, Scherer DJ, Williams KF, et al. Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients: A 5-Year Follow-Up Observational Cohort Study. Kidney360 (2021) 2(7):1141–7. 10.34067/KID.0000692021 PubMed DOI PMC

Voorzaat BM, Janmaat CJ, Wilschut ED, Van Der Bogt KE, Dekker FW, Rotmans JI. No Consensus on Physicians’ Preferences on Vascular Access Management after Kidney Transplantation: Results of a Multi-National Survey. J Vasc Access (2019) 20(1):52–9. 10.1177/1129729818776905 PubMed DOI PMC

Hicks CW, Bae S, Pozo ME, DiBrito SR, Abularrage CJ, Segev DL, et al. Practice Patterns in Arteriovenous Fistula Ligation Among Kidney Transplant Recipients in the United States Renal Data Systems. J Vasc Surg (2019) 70(3):842–52. 10.1016/j.jvs.2018.11.048 PubMed DOI

Golper TA, Hartle PM, Bian A. Arteriovenous Fistula Creation May Slow Estimated Glomerular Filtration Rate Trajectory. Nephrol Dial Transpl (2015) 30(12):2014–8. 10.1093/ndt/gfv082 PubMed DOI PMC

Van Hoek F, Scheltinga MR, Kouwenberg I, Moret KE, Beerenhout CH, Tordoir JH. Steal in Hemodialysis Patients Depends on Type of Vascular Access. Eur J Vasc Endovasc Surg (2006) 32(6):710–7. 10.1016/j.ejvs.2006.05.018 PubMed DOI

Valenti D, Mistry H, Stephenson M. A Novel Classification System for Autogenous Arteriovenous Fistula Aneurysms in Renal Access Patients. Vasc Endovascular Surg (2014) 48(7-8):491–6. 10.1177/1538574414561229 PubMed DOI

Sivananthan G, Menashe L, Halin NJ. Cephalic Arch Stenosis in Dialysis Patients: Review of Clinical Relevance, Anatomy, Current Theories on Etiology and Management. J Vasc Access (2014) 15:157–62. 10.5301/jva.5000203 PubMed DOI

Basile C, Lomonte C. The Complex Relationship Among Arteriovenous Access, Heart, and Circulation. Semin Dial (2018) 31(1):15–20. 10.1111/sdi.12652 PubMed DOI

Hetz P, Pirklbauer M, Müller S, Posch L, Gummerer M, Tiefenthaler M. Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation. Am J Nephrol (2020) 51(7):511–9. 10.1159/000508957 PubMed DOI PMC

Basile C, Vernaglione L, Casucci F, Libutti P, Lisi P, Rossi L, et al. The Impact of Haemodialysis Arteriovenous Fistula on Haemodynamic Parameters of the Cardiovascular System. Clin Kidney J (2016) 9(5):729–34. 10.1093/ckj/sfw063 PubMed DOI PMC

Malik J, Lomonte C, Rotmans J, Chytilova E, Roca-Tey R, Kusztal M, et al. Hemodialysis Vascular Access Affects Heart Function and Outcomes: Tips for Choosing the Right Access for the Individual Patient. J Vasc Access (2021) 22(1_Suppl. l):32–41. 10.1177/1129729820969314 PubMed DOI PMC

London GM, Guerin AP, Marchais SJ. Hemodynamic Overload in End-Stage Renal Disease Patients. Semin Dial (1999) 12:77–83. 10.1046/j.1525-139x.1999.00007.x DOI

Iwashima Y, Horio T, Takami Y, Inenaga T, Nishikimi T, Takishita S, et al. Effects of the Creation of Arteriovenous Fistula for Hemodialysis on Cardiac Function and Natriuretic Peptide Levels in CRF. Am J Kidney Dis (2002) 40:974–82. 10.1053/ajkd.2002.36329 PubMed DOI

Pfitzner J. Poiseuille and His Law. Anaesthesia (1976) 31:273–5. 10.1111/j.1365-2044.1976.tb11804.x PubMed DOI

Sho E, Sho M, Singh TM, Nanjo H, Komatsu M, Xu C, et al. Arterial Enlargement in Response to High Flow Requires Early Expression of Matrix Metalloproteinases to Degrade Extracellular Matrix. Exp Mol Pathol (2002) 73:142–53. 10.1006/exmp.2002.2457 PubMed DOI

Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A. Role of Matrix Metalloproteinases in Blood Flow-Induced Arterial Enlargement: Interaction with NO. Arterioscler Thromb Vasc Biol (2000) 20(12):E120–6. 10.1161/01.atv.20.12.e120 PubMed DOI

Malik J, Valerianova A, Tuka V, Trachta P, Bednarova V, Hruskova Z, et al. The Effect of High-Flow Arteriovenous Fistulas on Systemic Haemodynamics and Brain Oxygenation. ESC Heart Fail (2021) 8(3):2165–71. 10.1002/ehf2.13305 PubMed DOI PMC

Unger P, Wissing KM, de Pauw L, Neubauer J, van de Borne P. Reduction of Left Ventricular Diameter and Mass after Surgical Arteriovenous Fistula Closure in Renal Transplant Recipients. Transplantation (2002) 74(1):73–9. 10.1097/00007890-200207150-00013 PubMed DOI

Van Duijnhoven EC, Cheriex EC, Tordoir JH, Kooman JP, van Hooff JP. Effect of Closure of the Arteriovenous Fistula on Left Ventricular Dimensions in Renal Transplant Patients. Nephrol Dial Transpl (2001) 16(2):368–72. 10.1093/ndt/16.2.368 PubMed DOI

Stoumpos S, Van Rhijn P, Mangion K, Thomson PC, Mark PB. Arteriovenous Fistula for Haemodialysis as a Predictor of PubMed DOI PMC

Valerianova A, Lachmanova J, Kovarova L, Kmentova T, Bartkova M, Malik J. Factors Responsible for Cerebral Hypoxia in Hemodialysis Population. Physiol Res (2019) 68:651–8. 10.33549/physiolres.934064 PubMed DOI

Yasir MB, Man RK, Gogikar A, Nanda A, Niharika Janga LS, Sambe HG, et al. A Systematic Review Exploring the Impact of Arteriovenous Fistula Ligature on High-Output Heart Failure in Renal Transplant Recipients. Ann Vasc Surg (2024) 100:67–80. 10.1016/j.avsg.2023.10.010 PubMed DOI

Mitchell RN, Libby P. Vascular Remodeling in Transplant Vasculopathy. Circ Res (2007) 100(7):967–78. 10.1161/01.RES.0000261982.76892.09 PubMed DOI

Reilly JM, Savage EB, Brophy CM, Tilson MD. Hydrocortisone Rapidly Induces Aortic Rupture in a Genetically Susceptible Mouse. Arch Surg (1990) 125:707–9. 10.1001/archsurg.1990.01410180025004 PubMed DOI

Viscardi A, Travaglino A, Del Guercio L, D’Armiento M, Santangelo M, Sodo M, et al. The Role of Immunosuppressive Therapy in Aneurysmal Degeneration of Hemodialysis Fistulas in Renal Transplant Patients. Ann Vasc Surg (2021) 74:21–8. 10.1016/j.avsg.2021.01.097 PubMed DOI

Trampuz BV, Arnol M, Gubensek J, Ponikvar R, Ponikvar JB. A National Cohort Study on Hemodialysis Arteriovenous Fistulas after Kidney Transplantation - Long-Term Patency, Use and Complications. BMC Nephrol (2021) 22(1):344. 10.1186/s12882-021-02550-4 PubMed DOI PMC

Janeckova J, Bachleda P, Utikal P, Orsag J. Management of Arteriovenous Fistula after Successful Kidney Transplantation in Long-Term Follow-Up. Transpl Int (2024) 37:12841. 10.3389/ti.2024.12841 PubMed DOI PMC

Dammers R, Tordoir JHM, Kooman JP, Welten RJTJ, Hameleers JMM, Kitslaar PJEHM, et al. The Effect of Flow Changes on the Arterial System Proximal to an Arteriovenous Fistula for Hemodialysis. Ultrasound Med Biol (2005) 31:1327–33. 10.1016/j.ultrasmedbio.2005.03.017 PubMed DOI

Janeckova J, Bachleda P, Koleckova M, Utikal P. Brachial Artery Aneurysm as A LATE Complication of Arteriovenous Fistula. J Vasc Access (2023) 24(5):926–32. 10.1177/11297298211059326 PubMed DOI

Khalid U, Parkinson F, Mohiuddin K, Davies P, Woolgar J. Brachial Artery Aneurysms Following Brachio-Cephalic AV Fistula Ligation. J Vasc Access (2014) 15(1):22–4. 10.5301/jva.5000156 PubMed DOI

Mestres G, Fontsere N, Yugueros X, Tarazona M, Ortiz I, Riambau V. Aneurysmal Degeneration of the Inflow Artery after Arteriovenous Access for Hemodialysis. Eur J Vasc Endovasc Surg (2014) 48(592e596):592–6. 10.1016/j.ejvs.2014.08.011 PubMed DOI

Marzelle J, Gashi V, Nguyen H-D, Mouton A, Becquemin J-P, Bourquelot P. Aneurysmal Degeneration of the Donor Artery after Vascular Access. J Vasc Surg (2012) 55:1052–7. 10.1016/j.jvs.2011.10.112 PubMed DOI

Chemla E, Nortley M, Morsy M. Brachial Artery Aneurysms Associated with Arteriovenous Access for Hemodialysis. Semin Dial (2010) 23:440–4. 10.1111/j.1525-139X.2010.00718.x PubMed DOI

Kittitirapong N, Jinawath A, Horsirimanont S. Angiosarcoma in Arteriovenous Fistula after Kidney Transplantation. J Vasc Surg Cases Innov Tech (2021) 7(1):142–7. 10.1016/j.jvscit.2020.12.016 PubMed DOI PMC

Paral KM, Raca G, Krausz T. MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site. Case Rep Pathol (2015) 2015:537297. 10.1155/2015/537297 PubMed DOI PMC

Aldaabil RA, Alkhunaizi AM, Dawsari NA, Dawamneh MF, Rabah R. Angiosarcoma at the Site of Nonfunctioning Arteriovenous Fistula in a Kidney Transplant Recipient. J Vasc Surg Cases Innov Tech (2016) 2(2):53–5. 10.1016/j.jvsc.2016.03.004 PubMed DOI PMC

Kousios A, Storey R, Barnes ET, Hamady M, Salisbury E, Duncan N, et al. Plasmacytoma-Like Posttransplant Lymphoproliferative Disease in a Disused Arteriovenous Fistula: The Importance of Histopathology. Kidney Int Rep (2019) 4(5):749–55. 10.1016/j.ekir.2019.02.003 PubMed DOI PMC

Oskrochi Y, Razi K, Stebbing J, Crane J. Angiosarcoma and Dialysis-Related Arteriovenous Fistulae: A Comprehensive Review. Eur J Vasc Endovasc Surg (2016) 51:127–33. 10.1016/j.ejvs.2015.08.016 PubMed DOI

Hashimoto T, Akagi D, Yamamoto S, Suhara M, Sato O, Deguchi J. Short Interposition with a Small-Diameter Prosthetic Graft for Flow Reduction of a High-Flow Arteriovenous Fistula. J Vasc Surg (2021) 73(1):285–90. 10.1016/j.jvs.2020.05.035 PubMed DOI

Gerrickens MWM, Vaes RHD, Govaert B, Loon MV, Tordoir JH, Hoek VH, et al. Three Year Patency and Recurrence Rates of Revision Using Distal Inflow with a Venous Interposition Graft for High Flow Brachial Artery Based Arteriovenous Fistula. Eur J Vasc Endovasc Surg (2018) 55(6):874–81. 10.1016/j.ejvs.2018.03.014 PubMed DOI

Chang R, Alabi O, Mahajan A, Miller JS, Bhat KR, Mize BM, et al. Arteriovenous Fistula Aneurysmorrhaphy Is Associated with Improved Patency and Decreased Vascular Access Abandonment. J Vasc Surg (2023) 77(3):891–8.e1. 10.1016/j.jvs.2022.10.054 PubMed DOI

Lee H, Thomas SD, Paravastu S, Barber T, Varcoe RL. Dynamic Banding (DYBAND) Technique for Symptomatic High-Flow Fistulae. Vasc Endovascular Surg (2020) 54(1):5–11. 10.1177/1538574419874934 PubMed DOI

Mallios A, Gaudin A, Haugue A, Blic RD, Boura B, Jennings WC. Customizable Modification of Banding with External Stenting for Arteriovenous Fistula Flow Reduction. J Vasc Surg Cases Innov Tech (2022) 8(2):151–7. 10.1016/j.jvscit.2022.01.003 PubMed DOI PMC

Letachowicz K, Banasik M, Królicka A, Mazanowska O, Gołębiowski T, Augustyniak-Bartosik H, et al. Vascular Access Perspectives in Patients after Kidney Transplantation. Front Surg (2021) 8:640986. 10.3389/fsurg.2021.640986 PubMed DOI PMC

Weyde W, Letachowicz W, Krajewska M, Golebiowski T, Letachowicz K, Kusztal M, et al. Vascular Access Perspectives in Patients after Kidney Transplantation. Clin Transpl (2008) 22:185–90. 10.1111/j.1399-0012.2007.00767.x PubMed DOI

Gołębiowski T, Letachowicz K, Letachowicz W, Kusztal M, Garcarek J, Strempska B, et al. Use of the Subcutaneous Venous Network of the Forearm to Create an Arteriovenous Fistula. Hemodial Int (2015) 19(4):E24–8. 10.1111/hdi.12304 PubMed DOI

Ulloa JG, Jimenez JC, Pantoja JL, Farley SM, Gelabert HA, Rigberg DA, et al. Elective Resection of Symptomatic Arteriovenous Fistulae and Grafts in Patients with Functioning Renal Allografts at A High Volume Transplant Hospital. Ann Vasc Surg (2021) 76:449–53. 10.1016/j.avsg.2021.03.048 PubMed DOI

Fraser CD, Grimm JG, Liu RH, Wesson RN, Azar F. Removal of Non-Infected Arteriovenous Fistulae Following Kidney Transplantation Is a Safe and Beneficial Management Strategy for Unused Dialysis AccessAnn. Vasc Surg (2018) 53:128–32. 10.1016/j.avsg.2018.04.020 PubMed DOI

Van der Veer SN, Haller MC, Pittens CA, Broerse J, Castledine C, Gallieni M, et al. Setting Priorities for Optimizing Vascular Access Decision Making--An International Survey of Patients and Clinicians. PloS one (2015) 10(7):e0128228. 10.1371/journal.pone.0128228 PubMed DOI PMC

Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis (2020) 75(4 Suppl. 2):S1–S164. 10.1053/j.ajkd.2019.12.001 PubMed DOI

Fluck R, Kumwenda M. Renal Association Clinical Practice Guideline on Vascular Access for Haemodialysis. Nephron Clin Pract (2011) 118(Suppl. 1):c225–40. 10.1159/000328071 PubMed DOI

Bardowska K, Letachowicz K, Kaminska D, Kusztal M, Golebiowski T, Krolicki T, et al. The Attitude of Kidney Transplant Recipients towards Elective Arteriovenous Fistula Ligation. PloS one (2020) 15(7):e0234931. 10.1371/journal.pone.0234931 PubMed DOI PMC

Letachowicz K, Bardowska K, Królicki T, Kamińska D, Banasik M, Zajdel K, et al. The Impact of Location and Patency of the Arteriovenous Fistula on Quality of Life of Kidney Transplant Recipients. Ren Fail (2021) 43(1):113–22. 10.1080/0886022X.2020.1865171 PubMed DOI PMC

Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Ravel VA, et al. Association between Vascular Access Creation and Deceleration of Estimated Glomerular Filtration Rate Decline in Late-Stage Chronic Kidney Disease Patients Transitioning to End-Stage Renal Disease. Nephrol Dial Transpl (2017) 32(8):1330–7. 10.1093/ndt/gfw220 PubMed DOI PMC

Hahn Lundström U, Hedin U, Gasparini A, Caskey FJ, Carrero JJ, Evans M. Arteriovenous Access Placement and Renal Function Decline. Nephrol Dial Transpl (2021) 36(2):275–80. 10.1093/ndt/gfz221 PubMed DOI

Dupuis MÈ, Laurin LP, Goupil R, Bénard V, Pichette M, Lafrance JP, et al. Arteriovenous Fistula Creation and Estimated Glomerular Filtration Rate Decline in Advanced CKD: A Matched Cohort Study. Kidney360 (2020) 2(1):42–9. 10.34067/KID.0005072020 PubMed DOI PMC

Locatelli F, Zoccali C. Arteriovenous Fistula as a Nephroprotective Intervention in Advanced CKD: Scientific Discovery and Explanation, and the Evaluation of Interventions. Nephrol Dial Transpl (2015) 30(12):1939–41. 10.1093/ndt/gfv281 PubMed DOI PMC

Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, et al. Remote Ischaemic Conditioning before Hospital Admission, as a Complement to Angioplasty, and Effect on Myocardial Salvage in Patients with Acute Myocardial Infarction: A Randomised Trial. Lancet (2010) 375(9716):727–34. 10.1016/S0140-6736(09)62001-8 PubMed DOI

Yang Y, Lang XB, Zhang P, Lv R, Wang YF, Chen JH. Remote Ischemic Preconditioning for Prevention of Acute Kidney Injury: A Meta-Analysis of Randomized Controlled Trials. Am J Kidney Dis (2014) 64(4):574–83. 10.1053/j.ajkd.2014.04.029 PubMed DOI

Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW. Effects of Arteriovenous Fistula Formation on Arterial Stiffness and Cardiovascular Performance and Function. Nephrol Dial Transpl (2011) 26(10):3296–302. 10.1093/ndt/gfq851 PubMed DOI

Burchell AE, Lobo MD, Sulke N, Sobotka PA, Paton JF. Arteriovenous Anastomosis: Is This the Way to Control Hypertension? Hypertension (2014) 64(1):6–12. 10.1161/HYPERTENSIONAHA.114.02925 PubMed DOI

Unger P, Wissing KM. Arteriovenous Fistula after Renal Transplantation: Utility, Futility or Threat? Nephrol Dial Transpl (2006) 21(2):254–7. 10.1093/ndt/gfi276 PubMed DOI

Vanderweckene P, Weekers L, Lancellotti P, Jouret F. Controversies in the Management of the Haemodialysis-Related Arteriovenous Fistula Following Kidney Transplantation. Clin Kidney J (2018) 11(3):406–12. 10.1093/ckj/sfx113 PubMed DOI PMC

Vajdič B, Arnol M, Ponikvar R, Kandus A, Buturović-Ponikvar J. Functional Status of Hemodialysis Arteriovenous Fistula in Kidney Transplant Recipients as a Predictor of Allograft Function and Survival. Transpl Proc (2010) 42(10):4006–9. 10.1016/j.transproceed.2010.09.057 PubMed DOI

Weekers L, Vanderweckene P, Pottel H, Castanares-Zapatero D, Bonvoisin C, Hamoir E, et al. The Closure of Arteriovenous Fistula in Kidney Transplant Recipients Is Associated with an Acceleration of Kidney Function Decline. Nephrol Dial Transpl (2017) 32(1):196–200. 10.1093/ndt/gfw351 PubMed DOI

Aitken E, Kingsmore D. The Fate of the Fistula Following Renal Transplantation. Transpl Int (2014) 27(9):e90–1. 10.1111/tri.12326 PubMed DOI

Manca O, Pisano GL, Carta P, Manca EM, Piredda GB, Pili G, et al. The Management of Hemodialysis Arteriovenous Fistulas in Well Functioning Renal Transplanted Patients: Many Doubts, Few Certainties. J Vasc Access (2005) 6(4):182–6. 10.1177/112972980500600405 PubMed DOI

Joyce CZ, Al-Jaishi A, Perl J, Garg AX, Moist LM. Hemodialysis Arteriovenous Vascular Access Creation after Kidney Transplant Failure. Am J Kidney Dis (2015) 66(4):646–54. 10.1053/j.ajkd.2015.03.031 PubMed DOI

Khalil AK, Wish JB. Hemodialysis Access in Patients with Failed Kidney Transplants: Nephrologist. Heal Thyself Am J Kidney Dis (2015) 66(4):555–7. 10.1053/j.ajkd.2015.07.003 PubMed DOI

Haq NU, Abdelsalam MS, Althaf MM, Khormi AA, Harbi HA, Alshamsan B, et al. Vascular Access Types in Patients Starting Hemodialysis after Failed Kidney Transplant: Does Close Nephrology Follow-Up Matter? J Vasc Access (2017) 18(1):22–5. 10.5301/jva.5000631 PubMed DOI

Schmidli J, Widmer MK, Basile C, de Donato G, Gallieni M, Gibbons CP, et al. Editor's Choice - Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg (2018) 55(6):757–818. 10.1016/j.ejvs.2018.02.001 PubMed DOI

Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, et al. EBPG on Vascular Access. Nephrol Dial Transpl (2007) 22(Suppl. 2):ii88–117. 10.1093/ndt/gfm021 PubMed DOI

Wilmink T, Hollingworth L, Dasgupta I. Access Ligation in Transplant Patients. J Vasc Access (2016) 17(Suppl. 1):S64–8. 10.5301/jva.5000537 PubMed DOI

O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the Prevention of Intravascular Catheter-Related Infections. Clin Infect Dis (2011) 52(9):e162–93. 10.1093/cid/cir257 PubMed DOI PMC

Bouza E, Burillo A, Guembe M. Managing Intravascular Catheter-Related Infections in Heart Transplant Patients: How Far Can We Apply IDSA Guidelines for Immunocompromised Patients? Curr Opin Infect Dis (2011) 24(4):302–8. 10.1097/QCO.0b013e328348b1b9 PubMed DOI

Karim MS, Aryal P, Gardezi A, Clark DF, Aziz F, Parajuli S. Vascular Access in Kidney Transplant Recipients. Transpl Rev (Orlando) (2020) 34(3):100544. 10.1016/j.trre.2020.100544 PubMed DOI

Xiao Z, Rotmans JI. Considering the Closure of Arteriovenous Fistulas in Kidney Transplant Recipients. Kidney360 (2023) 4(8):1019–20. 10.34067/KID.0000000000000235 PubMed DOI PMC

Lee SR, Thorn S, Guerrera N, Gonzalez L, Taniguchi R, Langford J, et al. Arteriovenous Fistula-Induced Cardiac Remodeling Shows Cardioprotective Features in Mice. JVS Vasc Sci (2021) 2:110–28. 10.1016/j.jvssci.2021.05.002 PubMed DOI PMC

Reddy YNV, Obokata M, Dean PG, Melenovsky V, Nath KA, Borlaug BA. Long-Term Cardiovascular Changes Following Creation of Arteriovenous Fistula in Patients with End Stage Renal Disease. Eur Heart J (2017) 38(24):1913–23. 10.1093/eurheartj/ehx045 PubMed DOI

Kolonko A, Kujawa-Szewieczek A, Szotowska M, Kuczera P, Chudek J, Więcek A. The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients. Biomed Res Int (2014) 2014:603459. 10.1155/2014/603459 PubMed DOI PMC

Middleton RJ, Parfrey PS, Foley RN. Left Ventricular Hypertrophy in the Renal Patient. J Am Soc Nephrol (2001) 12(5):1079–84. 10.1681/ASN.V1251079 PubMed DOI

Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic Left Ventricular Hypertrophy in Renal Transplant Recipients: Prognostic Value and Impact of Blood Pressure and Anemia. J Am Soc Nephrol (2003) 14(2):462–8. 10.1097/01.asn.0000043141.67989.39 PubMed DOI

Unger P, Velez-Roa S, Wissing KM, Hoang AD, van de Borne P. Regression of Left Ventricular Hypertrophy after Arteriovenous Fistula Closure in Renal Transplant Recipients: A Long-Term Follow-Up. Am J Transpl (2004) 4(12):2038–44. 10.1046/j.1600-6143.2004.00608.x PubMed DOI

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...